Next Article in Journal
Evaluation of the Impact of Mild Steaming and Heat Treatment on the Concentration of Okadaic Acid, Dinophysistoxin-2 and Dinophysistoxin-3 in Mussels
Next Article in Special Issue
Evolution of the SpoIISABC Toxin-Antitoxin-Antitoxin System in Bacilli
Previous Article in Journal
Is qPCR a Reliable Indicator of Cyanotoxin Risk in Freshwater?
Previous Article in Special Issue
Identification and Characterization of the HicAB Toxin-Antitoxin System in the Opportunistic Pathogen Pseudomonas aeruginosa
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Toxins
Volume 8
Issue 6
10.3390/toxins8060174
toxins-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

AAU-Specific RNA Cleavage Mediated by MazF Toxin Endoribonuclease Conserved in Nitrosomonas europaea

by
Tatsuki Miyamoto
1,2,
Akiko Yokota
2,
Satoshi Tsuneda
1,* and
Naohiro Noda
1,2,*
1
Department of Life Science and Medical Bioscience, Waseda University, Shinjuku-ku, Tokyo 162-8480, Japan
2
Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki 305-8566, Japan
*
Authors to whom correspondence should be addressed.
Toxins 2016, 8(6), 174; https://doi.org/10.3390/toxins8060174
Submission received: 22 March 2016 / Accepted: 30 May 2016 / Published: 4 June 2016
(This article belongs to the Special Issue Toxin-Antitoxin System in Bacteria)
Browse Figures
Versions Notes

Abstract

:
Nitrosomonas europaea carries numerous toxin-antitoxin systems. However, despite the abundant representation in its chromosome, studies have not surveyed the underlying molecular functions in detail, and their biological roles remain enigmatic. In the present study, we found that a chromosomally-encoded MazF family member, predicted at the locus NE1181, is a functional toxin endoribonuclease, and constitutes a toxin-antitoxin system, together with its cognate antitoxin, MazE. Massive parallel sequencing provided strong evidence that this toxin endoribonuclease exhibits RNA cleavage activity, primarily against the AAU triplet. This sequence-specificity was supported by the results of fluorometric assays. Our results indicate that N. europaea alters the translation profile and regulates its growth using the MazF family of endoribonuclease under certain stressful conditions.

Graphical Abstract

1. Introduction

Nitrosomonas europaea is a chemolithoautotrophic bacterium in the beta-subdivision of Proteobacteria [1]. It inhabits aquatic and terrestrial environments and acquires reductants by oxidizing ammonia to nitrite [2]. Since ammonia oxidization is a key reaction in both the ecological nitrogen cycle and environmental engineering [3], the physiological responses of N. europaea in a variety of environments have been investigated; it is now widely accepted that this bacterium responds sensitively to environmental changes such as temperature, ammonia concentration, pH, nitrite concentration, inorganic substances, and organic compounds [4,5,6,7,8].
The genome information of this bacterium was previously published [9]. Interestingly, N. europaea bears a large number of putative toxin-antitoxin (TA) systems, which are stress-responsible genetic modules widespread in bacterial and archaeal lineages. This indicates that N. europaea acclimates to variable environments using these systems [10]. However, no studies have surveyed the molecular functions of these TA systems conserved in this chemolithoautotroph.
TA systems are typically encoded by a set of two genes: one for a long-lived toxin that inhibits vital processes in microbial cells and the other for a short-lived antitoxin that neutralizes toxin activity [11]. In most cases, antitoxins are preferentially degraded under stressful conditions. This results in toxin liberation and subsequent growth arrest [11]. Although the cellular targets of toxins are diverse, most previously identified toxins are known to arrest microbial growth by cleaving intracellular RNAs [12].
Escherichia coli MazF, which belongs to the MazEF family with its cognate antitoxin MazE, is one of the best-characterized toxins [13]. Under stressful environments, MazF specifically cleaves cellular RNAs at ACA sites irrespective of the ribosome [14], serving as a post-transcriptional regulator [15,16]. Interestingly, MazF homologues are well-conserved in the prokaryotic domain [10,17]. Additionally, they cleave discrete RNA sites based on recognition length and sequences [14,18,19,20,21,22,23,24,25,26,27,28]. Therefore, MazF homologues are thought to play diverse biological roles; indeed, they have been implicated in programmed cell death [29], dormancy [30], phage abortive infection [31,32], and pathogenicity [21,22,33].
In the present study, we showed a MazF homologue, predicted at NE1181 in the N. europaea chromosome (MazFNE1181), is a toxin endoribonuclease, which forms a TA pair together with its cognate antitoxin MazE, encoded by the NE1182 locus (MazENE1182). Using a combination of RNA-seq and fluorometric assays, this enzyme was found to cleave AAU sites in a sequence-specific manner. These results indicate that N. europaea translation is altered by the action of this enzyme during specific environmental stresses.

2. Results

2.1. Enzymatic Activity of MazFNE1181

MazFNE1181 codes for a 113-residue protein and shows 26.9% identity to E. coli MazF (MazFec) (Figure 1A), but its function remains unclear. We purified histidine-tagged MazFNE1181 (Figure 1B) and then examined its endoribonuclease activity. We incubated a 533-nt RNA with this enzyme, and observed RNA degradation (Figure 1C, Lane 3), which suggests that MazFNE1181 is a toxin endoribonuclease. Next, in order to rule out the potential contamination with RNases, a cognate MazE antitoxin (MazENE1182) was purified (Figure 1B). The addition of MazENE1182 was shown to block RNA cleavage (Figure 1C, Lanes 4–6), demonstrating that it is specifically mediated by MazFNE1181. Moreover, the cleavage patterns differed between MazFec- and MazFNE1181-treated RNAs (Figure 1D). Taken together with the fact that both MazF proteins yielded numerous RNA fragments, it appears that MazFNE1181 recognizes short unique sequences.

2.2. Cleavage Sequence Identification Using Massive Parallel Sequencing

We recently developed an RNA-seq-based approach for cleavage sequence determination [25]. Hence, we attempted to define the cleavage specificity of MazFNE1181 using this approach (see Appendix A). When analyzing the MazFNE1181-cleaved RNA sites, we found that the AAT triplet was highly conserved (Figure 2B), suggesting that MazFNE1181 preferably recognizes and cuts RNAs at the unique triplet AAU. Furthermore, since the coverage significantly increased at the second A-residue (Table S1 and Figure 2B), MazFNE1181 likely cleaves RNAs between the first and second adenines.

2.3. Cleavage-Specificity Validation Based on Fluorescence Resonance Energy Transfer

To further confirm its sequence-specificity, we next examined whether MazFNE1181 cleaves fluorescent-modified oligonucleotides (Table 1) based on fluorescence resonance energy transfer (see Appendix B) [25,34].
In agreement with the results obtained from RNA-seq, when a chimeric DNA/RNA oligonucleotide DR-13-AAU was first treated with MazFNE1181, fluorescent intensity rapidly increased (Figure 3A), verifying that AAU is the target of this enzyme. Therefore, we next examined whether AAA was also susceptible to this enzyme, since this triplet was detected by massive parallel sequencing (Figure 2B, Table S1). We synthesized DR-13-AAA and incubated it with MazFNE1181. As expected, the AAA triplet was also cleaved, but the cleavage activity was greatly weakened (Figure 3B); indeed, while DR-13-AAU was completely cleaved within 15 min, nearly 50% of DR-13-AAA remained intact, even at the end of the reaction. Thus, AAU was considered to be the main target of the enzyme.
Notably, a DNA oligonucleotide that is composed of a DNA adenine repeat (D-13-AAA) was tolerant to MazFNE1181 (Figure S1A). Furthermore, MazFNE1181-mediated RNA cleavage was nearly completely blocked for three RNA oligonucleotides (R-13-GUUGU, R-13-UCUCG, and R-13-UGACA) (Figures S1B–D), the sequences of which were derived from substrate RNA used in the RNA-seq but did not include the AAU and AAA sequences. Taking these results together with the results showing that DR-13-AAU cleavage was counteracted by the addition of MazENE1182 in a dose-dependent manner (Figure S2), the possibility of contamination by DNases and RNases was, again, excluded.
Finally, we prepared two additional fluorogenic oligonucleotides (DR-13-GAU and DR-13-AAC) to investigate whether MazFNE1181 strictly recognizes specific sequences. As anticipated, neither DR-13-GAU, an oligonucleotide whose first RNA base A is substituted with another purine base G, nor DR-13-AAC, whose last RNA base U is substituted with another pyrimidine base C, were cleaved, demonstrating the strictness of MazFNE1181-recognition (Figure 3C,D). Thus, MazFNE1181 is a canonical toxin endoribonuclease that mainly targets the AAU sequence.

3. Discussion

TA systems are ubiquitous elements encoded in prokaryotic plasmids and chromosomes [10,35,36,37] and are involved in stress adaptation by modulating bacterial and archaeal growth. Although toxin molecules regulate microbial growth through a variety of mechanisms, an enormous number of toxins are known to function as RNA endoribonucleases. Based on the mode of action, these toxin endoribonucleases are classified into two categories: (i) ribosome-dependent endoribonucleases (i.e., RelE, YafQ, and HigB) [38,39,40] and (ii) ribosome-independent endoribonucleases (i.e., MazF, HicA, and VapC) [14,41,42].
In the current study, we demonstrated that the AAU site is the prime target of N. europara MazF (MazFNE1181) (Figure 2 and Figure 3). The consensus sequence for the MazFNE1181 was previously known as 5′-GAAU-3′ and 5′-AAAU-3′ [43]. However, these cleavage sequences were roughly estimated based on gel electrophoresis results. Using a combination of massive parallel sequencing and fluorometric assays, we refined the cleavage-specificity of MazFNE1181.
It has been well-established that transcripts without recognition sequences are tolerant to toxin endoribonucleases [21,22,44]. Accordingly, we extracted protein-coding sequences without any AAU triplets. We found that eight out of 2462 sequences were devoid of this triplet (Table 2).
Interestingly, three of eight genes were identified within mer operons (Table 2), which are composed of merTPCADE and merR (Table S2) [6,7]. Previously, these genes were inferred to be helpful for improving the resistance to mercury [6]. Furthermore, they were implicated in the resistance of N. europaea to other heavy metal stresses; in fact, these genes were significantly upregulated after heavy metal exposure [6,7]. Considering that some toxin endoribonucleases regulate gene expression by differentially destabilizing mRNAs, including recognition sequences [45], MazFNE1181 may function as a post-transcriptional regulator and improve heavy metal resistance by enriching the transcripts within this operon; indeed, mazEF expression at this locus was reported to be upregulated under zinc stress [7].
Additionally, the gene sequence in the locus NE1224 did not include AAU triplets (Table 2). RASTA-Bacteria, an automated web-based tool for identifying prokaryotic toxin-antitoxin systems [46], predicted that this gene codes for an antitoxin that comprises a TA system along with a VapC family of toxin endoribonucleases (NE1225) [35,46]. Given that protein antitoxins typically suppress the expression of the TA system by binding its promoter [47], this putative antitoxin (NE1224) may repress the expression of VapC toxin endoribonuclease, in which case N. europaea may utilize these endoribonucleases depending on their surroundings and acclimate to the environments by using RNAs that evade MazFNE1181 or VapC-catalyzed cleavage.
In conclusion, we found that MazFNE1181 is a functional enzyme and possesses endoribonuclease activity. In addition, this MazF homologue mainly recognizes and cleaves RNAs at AAU sites in a ribosome-independent manner. This indicates that N. europaea alters its translation and copes with certain stresses with the aid of this enzyme.

4. Materials and Methods

4.1. Plasmids and Oligonucleotides

The pET21c expression vector was purchased from Takara Bio Service (Shiga, Japan). pET19b expression vector encoding mazENE1182, with the codon usage optimized for recombinant protein expression in E. coli, was purchased from GenScript Japan (Tokyo, Japan). pMK-T encoding mazFNE1181, whose codon usage was optimized for recombinant protein expression in E. coli, was purchased from Life Technologies Japan Ltd. (Tokyo, Japan). Fluorescent-modified oligonucleotides were purchased from Japan Bio Services (Saitama, Japan).

4.2. Plasmid Construction

pMK-T encoding mazFNE1181 and pET21c were digested with XhoI and BamHI (Toyobo, Osaka, Japan). These linearized DNA fragments were cleaned using a MinElute PCR purification kit (Qiagen, Hilden, Germany). The mazFNE1181 fragment was then cloned into the multiple cloning sites of pET21c using a DNA ligation kit (Takara), generating the plasmid pET21c-mazFNE1181. E. coli strain DH5α (Nippon Gene, Tokyo, Japan) was transformed with pET21c-mazFNE1181, and this transformant was grown at 37 °C on LB plate containing 100 μg/mL ampicillin. pET21c-mazFNE1181 was extracted using the QIAprep Spin Miniprep Kit (Qiagen), and the sequence was confirmed using an AB 3500 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s protocol.

4.3. Expression of MazENE1182

E. coli strain BL21 (DE3) cells (BioDynamics Laboratory Inc., Tokyo, Japan) were transformed using pET19b-mazENE1182. These cells were pre-cultivated overnight in LB medium supplemented with 100 μg/mL ampicillin at 37 °C. Afterward, they were inoculated into 1 L of LB medium containing 100 μg/mL ampicillin. MazENE1182 was induced by the addition of 1 mM isopropyl β-d-1-thiogalactopyranoside, when OD600 reached approximately 1.0. After 3.5 h of incubation, the cells were harvested by centrifugation at 7000 g, and stored at −80 °C until further use.

4.4. Purification of MazENE1182

Recombinant MazENE1182 was purified as described previously with minor modifications [25]. E. coli cells containing MazENE1182 were thawed on ice and resuspended in 14 mL of binding buffer (20 mM sodium phosphate (pH 8.0), 300 mM NaCl, 40 mM imidazole, and 5 mM 2-mercaptoethanol). Afterward, these cells were incubated on ice for 5 min in the presence of 0.2 mg/mL lysozyme. The cells were lysed by sonication and collected by centrifugation at 7000 g for 15 min. Afterward, the supernatant was filtered through a 0.45-μm membrane (Millex, Darmstadt, Germany). After equilibrating a 1-mL His-Trap FF column (GE Healthcare, Little Chalfont, UK), the supernatant was applied to the column and washed with 32 column volumes of binding buffer using AKTA pure 25 (GE Healthcare). Deca-histidine tagged MazENE1182 was selectively eluted with the elution buffer using following program: flow rate, 1 mL/min; linear elution gradient, 20 column volumes; fraction size, 0.5 mL. The following composition of the elution buffer was used: 20 mM sodium phosphate (pH 8.0), 300 mM NaCl, 500 mM imidazole, and 5 mM 2-mercaptoethanol. The 38th fraction from the beginning of the elution program was used for further experiments. The molecular weight and purity were confirmed using the Agilent 2200 TapeStation P200 ScreenTape Assay (Agilent Technologies, Santa Clara, CA, USA). Protein concentration was determined using the Qubit Protein Assay Kit (Life Technologies, Carlsbad CA, USA).

4.5. Expression of MazFNE1181

E. coli strain BL21 (DE3) (Nippon Gene) was transformed with pET21c-mazFNE1181 via heat shock, and this transformant was pre-cultivated overnight in LB medium supplemented with 100 μg/mL ampicillin at 37 °C. Pre-cultivated E. coli cells were then inoculated into 1 L LB medium containing 100 μg/mL ampicillin and 3% NaCl and then incubated overnight. MazFNE1181 was induced by the addition of 1 mM isopropyl β-d-1-thiogalactopyranoside. After 3.5 h of incubation, the cells were harvested by centrifugation at 7000 g and then stored at −80 °C until use.

4.6. Purification of MazFNE1181

Recombinant MazFNE1181 was purified as described previously with minor modifications [25]. E. coli cells containing MazFNE1181 were thawed on ice and resuspended in 15 mL of binding buffer (20 mM sodium phosphate (pH 8.0), 0.05% Triton X-100, 300 mM NaCl, 40 mM imidazole, and 5 mM 2-mercaptoethanol). Suspended cells were then incubated on ice for 5 min in the presence of 0.2 mg/mL lysozyme. The cells were lysed by sonication and collected by centrifuging at 7000 g for 15 min. The supernatant was then filtered through a 0.45-μm membrane (Millex). After equilibrating a 1-mL His-Trap FF crude column (GE Healthcare), the supernatant was applied to the column and washed with 32 column volumes of binding buffer using AKTA pure 25 (GE Healthcare). Hexa-histidine tagged MazFNE1181 was selectively eluted, using the elution buffer, with following program: flow rate, 1 mL/min; linear elution gradient, 20 column volumes; fraction size, 0.5 mL. The elution buffer contained 20 mM sodium phosphate (pH 8.0), 0.05% Triton X-100, 300 mM NaCl, 500 mM imidazole, and 5 mM 2-mercaptoethanol. The 22th fraction from the beginning of the elution program was used for further experiments. The molecular weight and purity were confirmed using the Agilent 2200 TapeStation P200 ScreenTape Assay (Agilent Technologies). Protein concentration was determined using the Qubit Protein Assay Kit (Life Technologies).

4.7. Enzymatic Activity of MazFNE1181 and MazENE1182

Synthetic RNA constructs were prepared as described in our previous study [25]. Thirty picomoles of MazFNE1181 were pre-incubated with 20, 60, or 180 pmol of MazENE1182 at room temperature for 10 min. Following this, 100 ng of RNA 500-2 was added and the mixture was incubated at 37 °C for 30 min in MazF reaction buffer (20 mM Tris-HCl (pH 8.0), 1 mM dithiothreitol, 0.01% Triton X-100, and 4 U of recombinant RNase inhibitor (Takara)) in a final volume of 50 μL. Samples were purified by RNA Clean and Concentrator™-5 (Zymo Research, Orange, CA, USA) and the gel loading buffer II (Ambion, Austin, TX, USA) was added to each sample. They were incubated at 95 °C for 5 min and separated on a 10% polyacrylamide gel containing 7 M urea. RNA was stained using SYBR Gold (Life Technologies) and detected using a Typhoon 9210 imager (GE Healthcare).

4.8. Endoribonuclease Activity of MazFNE1181

Synthetic RNA constructs were prepared as described in our previous study [25]. RNA 500-2 was incubated with 10, 50, or 250 ng of MazFec or MazFNE1181 at 37 °C for 30 min in MazF reaction buffer in 25-μL reaction volume. Gel loading buffer II (Ambion) was added to each sample. These samples were incubated at 95 °C for 5 min and then separated on a 10% polyacrylamide gel containing 7 M urea. RNA was stained using SYBR Gold (Life Technologies) and then detected using a Typhoon 9210 imager (GE Healthcare).

4.9. Cleavage Sequence Identification

The cleavage sequence was identified using the protocols described in our previous study [25]. First, 1.5 μg of five RNA mixtures were incubated with 400 ng of MazFNE1181 at 37 °C for 30 min in MazF reaction buffer. Phosphorylation, barcode ligation, and sequencing library construction were performed as described by Miyamoto et al. [25]. Sequencing was performed using the MiSeq platform with the MiSeq 500 cycles reagent kit v2 (Illumina, San Diego, CA, USA) according to the manufacturer’s protocol. Sequence data was analyzed using CLC Genomics 7.5.1. The parameters described by Miyamoto et al. [25] were used for the analysis, and 25 sequences were analyzed using WebLogo [48]. The deep sequencing dataset was deposited into the DDBJ Sequence Read Archive (DRA004562).

4.10. Fluorometric Detection of MazFNE1181 Activity

The flurometric assay was performed as described previously [25]. Two hundred nanograms of MazFNE1181 or 1 U of RNase I (Epicentre Biotechnologies, Madison, WI, USA) were incubated with 20 pmol of fluorescent-labeled oligonucleotides in MazF reaction buffer in a total volume of 20 μL. All reactions were conducted at 37 °C in triplicate and fluorescent intensity was recorded every 1 min using a Light Cycler 480 system (Roche, Basel, Switzerland) with 483 nm excitation and 533 nm detection filters.

4.11. Neutralization of MazFNE1181-mediated Cleavage

Ten picomoles of MazFNE1181 were pre-incubated with 2, 10, or 50 pmol of MazENE1182 at room temperature for 10 min. Afterward, 20 pmol of fluorescent-labeled oligonucleotide (DR-13-AAU) was added, and the mixture was incubated at 37 °C in MazF reaction buffer in a final volume of 20 μL. All reactions were conducted at 37 °C in triplicate and fluorescent intensity was recorded every 1 min using a Light Cycler 480 system (Roche) with 483 nm excitation and 533 nm detection filters. In the control reactions, fluorescent intensities in the presence of 1 U of RNase I (Epicentre) and in the absence of enzymes were measured.

4.12. Accession Numbers

The GenBank accession numbers are as follows: mazENE1182 protein sequence (WP_011111771), mazFNE1181 protein sequence (WP_011111770) and artificially designed RNAs; 500-2 (AB610940), 1000-1 (AB610944), 1000-2 (AB610945), 1000-3 (AB610946), 1000-4 (AB610947), and 1000-5 (AB610948).

Supplementary Materials

The following are available online at www.mdpi.com/2072-6651/8/6/174/s1, Figure S1: MazFNE1181-mediated sequence-specific RNA cleavage, Figure S2: Neutralization of MazFNE1181-mediated RNA cleavage, Table S1: Twenty-five sequences with MazFNE1181 cleavage, Table S2: Genes consisting of mer operon.

Acknowledgments

This work was supported by JSPS KAKENHI Grant Number 15K14241.

Author Contributions

Tatsuki Miyamoto, Akiko Yokota, Satoshi Tsuneda, and Naohiro Noda conceived and designed the experiments; Tatsuki Miyamoto and Akiko Yokota performed the experiments; Tatsuki Miyamoto analyzed the data; and Tatsuki Miyamoto wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

The following abbreviations are used in this manuscript:
TAtoxin-antitoxin
6-FAM6-carboxyfluorescein
BHQ-1black hole quencher-1
RASTA-Bacteriarapid automated scan for toxins and antitoxins in bacteria

Appendix A

The five artificially designed RNAs (1000-1, 1000-2, 1000-3, 1000-4, and 1000-5) including 1000-nt diverse sequences were fragmented with MazFNE1181. These RNAs were sequenced using the Illumina MiSeq platform with slightly modified RNA-seq protocols. The sequencing reads, which contained cleavage sites in their 5'-ends, were mapped against five reference sequences. Nucleotides showing increases in coverage were consistent with the first base of the cleaved RNAs (Figure 2A). These nucleotides were differentially detected by extracting the positions showing a large relative coverage increase, which is the value defined as the coverage at the n + 1th position divided by the coverage at the nth position. Sequences located five bases upstream and five bases downstream of these nucleotides were then extracted (Table S1) as outlined in our previous study [25]. A total of 25 sequences (five sequences derived from five references) were analyzed using WebLogo.

Appendix B

Fluorogenic oligonucleotides modified with 6-carboxyfluorescein (6-FAM) at the 5′-end and black hole quencher-1 (BHQ-1) at the 3′-end were used in this study. The fluorescence from 6-FAM is typically quenched by BHQ-1, but when oligonucleotides are cleaved, these two dyes are no longer in close proximity and fluorescent intensity increases [25,34].

References

  1. Arp, D.J.; Sayavedra-Soto, L.A.; Hommes, N.G. Molecular biology and biochemistry of ammonia oxidation by Nitrosomonas europaea. Arch. Microbiol. 2002, 178, 250–255. [Google Scholar]
  2. Bothe, H.; Jost, G.; Schloter, M.; Ward, B.B.; Witzel, K. Molecular analysis of ammonia oxidation and denitrification in natural environments. FEMS Microbiol. Rev. 2000, 24, 673–690. [Google Scholar] [CrossRef] [PubMed]
  3. Arp, D.J.; Stein, L.Y. Metabolism of inorganic N compounds by ammonia-oxidizing bacteria. Crit. Rev. Biochem. Mol. Biol. 2003, 38, 471–495. [Google Scholar] [CrossRef] [PubMed]
  4. Groeneweg, J.; Sellner, B.; Tappe, W. Ammonia oxidation in Nitrosomonas at NH3 concentrations near km: Effects of pH and temperature. Water Res. 1994, 28, 2561–2566. [Google Scholar] [CrossRef]
  5. Stein, L.Y.; Arp, D.J. Loss of ammonia monooxygenase activity in Nitrosomonas europaea upon exposure to nitrite. Appl. Environ. Microbiol. 1998, 64, 4098–4102. [Google Scholar] [PubMed]
  6. Park, S.; Ely, R.L. Candidate stress genes of Nitrosomonas europaea for monitoring inhibition of nitrification by heavy metals. Appl. Environ. Microbiol. 2008, 74, 5475–5482. [Google Scholar] [CrossRef] [PubMed]
  7. Park, S.; Ely, R.L. Genome-wide transcriptional responses of Nitrosomonas europaea to zinc. Arch. Microbiol. 2008, 189, 541–548. [Google Scholar] [CrossRef] [PubMed]
  8. Gvakharia, B.O.; Permina, E.A.; Gelfand, M.S.; Bottomley, P.J.; Sayavedra-Soto, L.A.; Arp, D.J. Global transcriptional response of Nitrosomonas europaea to chloroform and chloromethane. Appl. Environ. Microbiol. 2007, 73, 3440–3445. [Google Scholar] [CrossRef] [PubMed]
  9. Chain, P.; Lamerdin, J.; Larimer, F.; Lao, V.; Land, M.; Hauser, L.; Klotz, M.; Norton, J.; Arciero, D.; Hommes, N.; et al. Complete genome sequence of the ammonia-oxidizing bacterium and obligate chemolithoautotroph Nitrosomonas europaea. J. Bacteriol. 2003, 185, 2759–2773. [Google Scholar] [CrossRef] [PubMed]
  10. Pandey, D.P.; Gerdes, K. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 2005, 33, 966–976. [Google Scholar] [CrossRef] [PubMed]
  11. Schuster, C.F.; Bertram, R. Toxin-antitoxin systems are ubiquitous and versatile modulators of prokaryotic cell fate. FEMS Microbiol. Lett. 2013, 340, 73–85. [Google Scholar] [CrossRef] [PubMed]
  12. Yamaguchi, Y.; Inouye, M. Regulation of growth and death in Escherichia coli by toxin-antitoxin systems. Nat. Rev. Microbiol. 2011, 9, 779–790. [Google Scholar] [CrossRef] [PubMed]
  13. Aizenman, E.; Engelberg-Kulka, H.; Glaser, G. An Escherichia coli chromosomal “addiction module” regulated by guanosine 3’,5'-bispyrophosphate: a model for programmed bacterial cell death. Proc. Natl. Acad. Sci. USA 1996, 93, 6059–6063. [Google Scholar] [CrossRef] [PubMed]
  14. Zhang, Y.; Zhang, J.; Hoeflich, K.P.; Ikura, M.; Qing, G.; Inouye, M. MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli. Mol. Cell 2003, 12, 913–923. [Google Scholar] [CrossRef]
  15. Amitai, S.; Kolodkin-Gal, I.; Hananya-Meltabashi, M.; Sacher, A.; Kulka, H.E. Escherichia coli MazF leads to the simultaneous selective synthesis of both "death proteins" and "survival proteins". PLoS Genet. 2009, 5. [Google Scholar] [CrossRef] [PubMed]
  16. Vesper, O.; Amitai, S.; Belitsky, M.; Byrgazov, K.; Kaberdina, A.C.; Engelberg-Kulka, H.; Moll, I. Selective translation of leaderless mRNAs by specialized ribosomes generated by MazF in Escherichia coli. Cell 2011, 147, 147–157. [Google Scholar] [CrossRef] [PubMed]
  17. Chopra, N.; Saumitra; Pathak, A.; Bhatnagar, R.; Bhatnagar, S. Linkage, mobility, and selfishness in the MazF family of bacterial toxins: A snapshot of bacterial evolution. Genome Biol. Evol. 2013, 5, 2268–2284. [Google Scholar] [CrossRef] [PubMed]
  18. Zhang, J.; Zhang, Y.; Zhu, L.; Suzuki, M.; Inouye, M. Interference of mRNA function by sequence-specific endoribonuclease PemK. J. Biol. Chem. 2004, 279, 20678–20684. [Google Scholar] [CrossRef] [PubMed]
  19. Zhang, Y.; Zhu, L.; Zhang, J.; Inouye, M. Characterization of ChpBK, an mRNA interferase from Escherichia coli. J. Biol. Chem. 2005, 280, 26080–26088. [Google Scholar] [CrossRef] [PubMed]
  20. Park, J.H.; Yamaguchi, Y.; Inouye, M. Bacillus subtilis MazF-bs (EndoA) is a UACAU-specific mRNA interferase. FEBS Lett. 2011, 585, 2526–2532. [Google Scholar] [CrossRef] [PubMed]
  21. Zhu, L.; Inoue, K.; Yoshizumi, S.; Kobayashi, H.; Zhang, Y.; Ouyang, M.; Kato, F.; Sugai, M.; Inouye, M. Staphylococcus aureus MazF specifically cleaves a pentad sequence, UACAU, which is unusually abundant in the mRNA for pathogenic adhesive factor SraP. J. Bacteriol. 2009, 191, 3248–3255. [Google Scholar] [CrossRef] [PubMed]
  22. Rothenbacher, F.P.; Suzuki, M.; Hurley, J.M.; Montville, T.J.; Kirn, T.J.; Ouyang, M.; Woychik, N.A. Clostridium difficile MazF toxin exhibits selective, not global, mRNA cleavage. J. Bacteriol. 2012, 194, 3464–3474. [Google Scholar] [CrossRef] [PubMed]
  23. Yamaguchi, Y.; Nariya, H.; Park, J.-H.; Inouye, M. Inhibition of specific gene expressions by protein-mediated mRNA interference. Nat. Commun. 2012, 3, 607. [Google Scholar] [CrossRef] [PubMed]
  24. Syed, M.A.; Koyanagi, S.; Sharma, E.; Jobin, M.C.; Yakunin, A.F.; Lévesque, C.M. The chromosomal mazEF locus of Streptococcus mutans encodes a functional type II toxin-antitoxin addiction system. J. Bacteriol. 2011, 193, 1122–1130. [Google Scholar] [CrossRef] [PubMed]
  25. Miyamoto, T.; Kato, Y.; Sekiguchi, Y.; Tsuneda, S.; Noda, N. Characterization of MazF-mediated sequence-specific RNA cleavage in Pseudomonas putida using massive parallel sequencing. PLoS ONE 2016, 11, e0149494. [Google Scholar] [CrossRef] [PubMed]
  26. Bukowski, M.; Lyzen, R.; Helbin, W.M.; Bonar, E.; Szalewska-Palasz, A.; Wegrzyn, G.; Dubin, G.; Dubin, A.; Wladyka, B. A regulatory role for Staphylococcus aureus toxin-antitoxin system PemIKSa. Nat. Commun. 2013, 4, 2012. [Google Scholar] [CrossRef] [PubMed]
  27. Zhu, L.; Phadtare, S.; Nariya, H.; Ouyang, M.; Husson, R.N.; Inouye, M. The mRNA interferases, MazF-mt3 and MazF-mt7 from Mycobacterium tuberculosis target unique pentad sequences in single-stranded RNA. Mol. Microbiol. 2008, 69, 559–569. [Google Scholar] [CrossRef] [PubMed]
  28. Zhu, L.; Zhang, Y.; Teh, J.S.; Zhang, J.; Connell, N.; Rubin, H.; Inouye, M. Characterization of mRNA interferases from Mycobacterium tuberculosis. J. Biol. Chem. 2006, 281, 18638–18643. [Google Scholar] [CrossRef] [PubMed]
  29. Nariya, H.; Inouye, M. MazF, an mRNA Interferase, Mediates Programmed Cell Death during Multicellular Myxococcus Development. Cell 2008, 132, 55–66. [Google Scholar] [CrossRef] [PubMed]
  30. Tripathi, A.; Dewan, P.C.; Siddique, S.A.; Varadarajan, R. MazF-induced growth inhibition and persister generation in Escherichia coli. J. Biol. Chem. 2014, 289, 4191–4205. [Google Scholar] [CrossRef] [PubMed]
  31. Hazan, R.; Engelberg-Kulka, H. Escherichia coli mazEF-mediated cell death as a defense mechanism that inhibits the spread of phage P1. Mol. Genet. Genomics 2004, 272, 227–234. [Google Scholar] [CrossRef] [PubMed]
  32. Alawneh, A.M.; Qi, D.; Yonesaki, T.; Otsuka, Y. An ADP-ribosyltransferase Alt of bacteriophage T4 negatively regulates the Escherichia coli MazF toxin of a toxin-antitoxin module. Mol. Microbiol. 2015, 99, 188–198. [Google Scholar] [CrossRef] [PubMed]
  33. Tiwari, P.; Arora, G.; Singh, M.; Kidwai, S.; Narayan, O.P.; Singh, R. MazF ribonucleases promote Mycobacterium tuberculosis drug tolerance and virulence in guinea pigs. Nat. Commun. 2015, 6, 6059. [Google Scholar] [CrossRef] [PubMed]
  34. Wang, N.R.; Hergenrother, P.J. A continuous fluorometric assay for the assessment of MazF ribonuclease activity. Anal. Biochem. 2007, 371, 173–183. [Google Scholar] [CrossRef] [PubMed]
  35. Shao, Y.; Harrison, E.M.; Bi, D.; Tai, C.; He, X.; Ou, H.Y.; Rajakumar, K.; Deng, Z. TADB: A web-based resource for Type 2 toxin-antitoxin loci in bacteria and archaea. Nucleic Acids Res. 2011, 39, 606–611. [Google Scholar] [CrossRef] [PubMed]
  36. Makarova, K.S.; Wolf, Y.I.; Koonin, E.V. Comprehensive comparative-genomic analysis of type 2 toxin-antitoxin systems and related mobile stress response systems in prokaryotes. Biol. Direct 2009, 4, 19. [Google Scholar] [CrossRef] [PubMed]
  37. Blower, T.R.; Short, F.L.; Rao, F.; Mizuguchi, K.; Pei, X.Y.; Fineran, P.C.; Luisi, B.F.; Salmond, G.P.C. Identification and classification of bacterial Type III toxin-antitoxin systems encoded in chromosomal and plasmid genomes. Nucleic Acids Res. 2012, 40, 6158–6173. [Google Scholar] [CrossRef] [PubMed]
  38. Christensen, S.K.; Gerdes, K. RelE toxins from Bacteria and Archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA. Mol. Microbiol. 2003, 48, 1389–1400. [Google Scholar] [CrossRef] [PubMed]
  39. Prysak, M.H.; Mozdzierz, C.J.; Cook, A.M.; Zhu, L.; Zhang, Y.; Inouye, M.; Woychik, N.A. Bacterial toxin YafQ is an endoribonuclease that associates with the ribosome and blocks translation elongation through sequence-specific and frame-dependent mRNA cleavage. Mol. Microbiol. 2009, 71, 1071–1087. [Google Scholar] [CrossRef] [PubMed]
  40. Christensen-Dalsgaard, M.; Jørgensen, M.G.; Gerdes, K. Three new RelE-homologous mRNA interferases of Escherichia coli differentially induced by environmental stresses. Mol. Microbiol. 2010, 75, 333–348. [Google Scholar] [CrossRef] [PubMed]
  41. Jørgensen, M.G.; Pandey, D.P.; Jaskolska, M.; Gerdes, K. HicA of Escherichia coli defines a novel family of translation-independent mRNA interferases in bacteria and archaea. J. Bacteriol. 2009, 191, 1191–1199. [Google Scholar] [CrossRef] [PubMed]
  42. Arcus, V.L.; Mckenzie, J.L.; Robson, J.; Cook, G.M. The PIN-domain ribonucleases and the prokaryotic VapBC toxin-antitoxin array. Protein Eng. Des. Sel. 2011, 24, 33–40. [Google Scholar] [CrossRef] [PubMed]
  43. Shimada, M.; Takayama, M.; Asada, K.; Kato, I. Endoribonuclease. U.S. Patent 7,989,184, 5 June 2012. [Google Scholar]
  44. Schifano, J.M.; Vvedenskaya, I.O.; Knoblauch, J.G.; Ouyang, M.; Nickels, B.E.; Woychik, N.A. An RNA-seq method for defining endoribonuclease cleavage specificity identifies dual rRNA substrates for toxin MazF-mt3. Nat. Commun. 2014, 5, 3538. [Google Scholar] [CrossRef] [PubMed]
  45. Wang, X.; Lord, D.M.; Hong, S.H.; Peti, W.; Benedik, M.J.; Page, R.; Wood, T.K. Type II toxin/antitoxin MqsR/MqsA controls type V toxin/antitoxin GhoT/GhoS. Environ. Microbiol. 2013, 15, 1734–1744. [Google Scholar] [CrossRef] [PubMed]
  46. Sevin, E.W.; Barloy-Hubler, F. RASTA-Bacteria: A web-based tool for identifying toxin-antitoxin loci in prokaryotes. Genome Biol. 2007, 8, R155. [Google Scholar] [CrossRef] [PubMed]
  47. Gerdes, K.; Christensen, S.K.; Løbner-Olesen, A. Prokaryotic toxin-antitoxin stress response loci. Nat. Rev. Microbiol. 2005, 3, 371–382. [Google Scholar] [CrossRef] [PubMed]
  48. Crooks, G.; Hon, G.; Chandonia, J.; Brenner, S. WebLogo: A sequence logo generator. Genome Res. 2004, 14, 1188–1190. [Google Scholar] [CrossRef] [PubMed]
Toxins 08 00174 g001 1024
Figure 1. A MazF homologue isolated from N. europaea. (A) Pairwise alignment of two MazF sequences; (B) molecular weight and purity of MazEF pair; (C) enzymatic activity of MazENE1182 and MazFNE1181. Lane 1, ladder; lane 2, control reaction without enzymes; lanes 3–6, 30 pmol of MazFNE1181 was added. For lanes 4–6, 20, 60, and 180 pmol of MazENE1182 was added, respectively; and (D) cleavage pattern of MazFec and MazFNE1181; Lane 1, ladder; lanes 2 and 6, control reactions without any enzymes; lanes 3–5, 10, 50, and 250 ng of MazFec was added, respectively; lanes 7–9, 10, 50, and 250 ng of MazFNE1181 was added, respectively; lane 10, 100 ng of RNase A was added as a control.
Figure 1. A MazF homologue isolated from N. europaea. (A) Pairwise alignment of two MazF sequences; (B) molecular weight and purity of MazEF pair; (C) enzymatic activity of MazENE1182 and MazFNE1181. Lane 1, ladder; lane 2, control reaction without enzymes; lanes 3–6, 30 pmol of MazFNE1181 was added. For lanes 4–6, 20, 60, and 180 pmol of MazENE1182 was added, respectively; and (D) cleavage pattern of MazFec and MazFNE1181; Lane 1, ladder; lanes 2 and 6, control reactions without any enzymes; lanes 3–5, 10, 50, and 250 ng of MazFec was added, respectively; lanes 7–9, 10, 50, and 250 ng of MazFNE1181 was added, respectively; lane 10, 100 ng of RNase A was added as a control.
Toxins 08 00174 g001
Toxins 08 00174 g002 1024
Figure 2. Analysis of the cleavage sequence of MazFNE1181. (A) Graph of the coverage (blue bar) and relative coverage increase (green line); and (B) conserved sequence around nucleotide positions with increased coverage. Nucleotide position with significant increases in coverage was set to zero.
Figure 2. Analysis of the cleavage sequence of MazFNE1181. (A) Graph of the coverage (blue bar) and relative coverage increase (green line); and (B) conserved sequence around nucleotide positions with increased coverage. Nucleotide position with significant increases in coverage was set to zero.
Toxins 08 00174 g002
Toxins 08 00174 g003 1024
Figure 3. MazFNE1181-mediated sequence-specific RNA cleavage. Two hundred nanograms of MazFNE1181 (green) was incubated with 20 pmol of fluorescent-modified oligonucleotides; (A) DR 13-AAU; (B) DR-13-AAA; (C) DR-13-GAU; and (D) DR-13-AAC. In the control reactions, fluorescent intensities in the presence of 1 U of RNase I (blue) and in the absence of enzymes (yellow) at each time point (left) and end point (right) were measured.
Figure 3. MazFNE1181-mediated sequence-specific RNA cleavage. Two hundred nanograms of MazFNE1181 (green) was incubated with 20 pmol of fluorescent-modified oligonucleotides; (A) DR 13-AAU; (B) DR-13-AAA; (C) DR-13-GAU; and (D) DR-13-AAC. In the control reactions, fluorescent intensities in the presence of 1 U of RNase I (blue) and in the absence of enzymes (yellow) at each time point (left) and end point (right) were measured.
Toxins 08 00174 g003
Table
Table 1. Fluorescent-modified oligonucleotides used in fluorometric assay.
Table 1. Fluorescent-modified oligonucleotides used in fluorometric assay.
NameSequence (5′ to 3′) a
DR-13-AAUAAAAAAAUAAAAA
DR-13-AAAAAAAAAAAAAAAA
D-13-AAAAAAAAAAAAAAAA
R-13-GUUGUGUUGUCAUGCCGG
R-13-UCUCGUCUCGGUGCGUUG
R-13-UGACAUGACACGAACCGC
DR-13-GAUAAAAAGAUAAAAA
DR-13-AACAAAAAAACAAAAA
a Underlined letters represent RNA nucleotides and the other letters represent DNA nucleotides.
Table
Table 2. Protein coding sequences without AAU sequences.
Table 2. Protein coding sequences without AAU sequences.
LocusGene SymbolLength (bp)Product Name
NE0390rpmH135LSU Ribosomal protein L34
NE2575merE237mercury resistance protein
NE0841merP276mercury scavenger protein
NE0842merT351mercuric transport protein
NE1224-264hypothetical protein
NE1344-279hypothetical protein
NE2523-231hypothetical protein
NE2538-912hypothetical protein

Share and Cite

MDPI and ACS Style

Miyamoto, T.; Yokota, A.; Tsuneda, S.; Noda, N. AAU-Specific RNA Cleavage Mediated by MazF Toxin Endoribonuclease Conserved in Nitrosomonas europaea. Toxins 2016, 8, 174. https://doi.org/10.3390/toxins8060174

AMA Style

Miyamoto T, Yokota A, Tsuneda S, Noda N. AAU-Specific RNA Cleavage Mediated by MazF Toxin Endoribonuclease Conserved in Nitrosomonas europaea. Toxins. 2016; 8(6):174. https://doi.org/10.3390/toxins8060174

Chicago/Turabian Style

Miyamoto, Tatsuki, Akiko Yokota, Satoshi Tsuneda, and Naohiro Noda. 2016. "AAU-Specific RNA Cleavage Mediated by MazF Toxin Endoribonuclease Conserved in Nitrosomonas europaea" Toxins 8, no. 6: 174. https://doi.org/10.3390/toxins8060174

APA Style

Miyamoto, T., Yokota, A., Tsuneda, S., & Noda, N. (2016). AAU-Specific RNA Cleavage Mediated by MazF Toxin Endoribonuclease Conserved in Nitrosomonas europaea. Toxins, 8(6), 174. https://doi.org/10.3390/toxins8060174

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop